Cellular Modulators of the NRF2/KEAP1 Signaling Pathway in Prostate Cancer
Prostate cancer is the second most common malignancy in men worldwide. Prostate cancer can be treated by surgery, radiotherapy and hormone therapy. The latter, in the form of androgen-deprivation therapy is needed to reduce prostate cancer progression at an advanced stage. Several studies demonstrat...
| المؤلفون الرئيسيون: | , , , |
|---|---|
| التنسيق: | مقال |
| اللغة: | English |
| منشور في: |
IMR Press
2023-07-01
|
| سلاسل: | Frontiers in Bioscience-Landmark |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://www.imrpress.com/journal/FBL/28/7/10.31083/j.fbl2807143 |